Utilization of an Alternative Docetaxel-based Intraperitoneal Chemotherapy Regimen in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma: A Continued Need for Ovarian Cancer Patients

American Journal of Clinical Oncology
David A BeckerKerri S Bevis

Abstract

The objective of this study was to report the tolerability and toxicity of a regimen consisting of intravenous (IV) docetaxel and intraperitoneal (IP) cisplatin and paclitaxel with granulocyte colony-stimulating factor support. We conducted a retrospective cohort study of patients with surgical stage II-IV epithelial ovarian, fallopian tube or primary peritoneal carcinoma treated with an outpatient IP chemotherapy regimen consisting of docetaxel 75 mg/m IV and cisplatin 75 mg/m IP day 1 followed by paclitaxel 60 mg/m IP day 8 every 21 days. Grade 3 and 4 toxicity, dose delays and reductions, port complications, and tolerability are reported. Outcomes, including response rate, progression-free survival (PFS), overall survival (OS) are also reported. A total of 60 patients received this IP regimen. Most common toxicities included neutropenia (47%), gastrointestinal (28%), and anemia (25%). Most patients (85%) experienced no IP port complications. Dose delay or reduction was required in 30% of patients. Two-thirds completed all prescribed cycles, with 80% of total planned cycles completed. Complete response was achieved for 88%, and 43% are currently without evidence of disease. Median PFS for all patients was 25.5 months (95% con...Continue Reading

References

Feb 13, 2001·British Journal of Cancer·P A VaseyS B Kaye
Oct 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G J RustinT Meyer
Nov 18, 2004·Journal of the National Cancer Institute·Paul A VaseyUNKNOWN Scottish Gynaecological Cancer Trials Group
Dec 14, 2004·The New England Journal of Medicine·Stephen A Cannistra
Jan 6, 2006·The New England Journal of Medicine·Deborah K ArmstrongUNKNOWN Gynecologic Oncology Group
Apr 11, 2008·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·E L Trimble, M C Christian
Feb 10, 2009·Gynecologic Oncology·Emily BerryJulian Schink
Oct 25, 2011·BJOG : an International Journal of Obstetrics and Gynaecology·C W Helm
Feb 15, 2012·Journal of Experimental & Clinical Cancer Research : CR·Ayako KimTakayuki Enomoto
Mar 5, 2016·The New England Journal of Medicine·John K ChanBradley J Monk
May 10, 2016·Obstetrics and Gynecology·Jason D WrightDawn L Hershman
Jan 6, 2017·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT01167712

Software Mentioned

SPSS

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.